Episode 1: When Should Treatment Start? What AML Patients Need to Know

Event Description
Does delaying treatment impact survival? Dr. Samuel Yates helps us break down new research on treatment timing and what it means for patients making critical care decisions.
Schedule & Agenda




Speakers & Moderators

Mary joined HealthTree in 2022. She is now the AML & MDS Community and Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Dr. Yates is a researcher interested in hematologic malignancies (especially leukemias, like AML) in older adults, with a specific interest in the assessment and intervention of nutrition and body composition in these patients.
Join the Conversation
This event is part of the Acute Myeloid Leukemia Discussion group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org


Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.